Ciprofloxacin/dexamethasone
Alternative Names: 0.3% Ciprofloxacin/0.1% dexamethasone; CiloDex; CiloDex otic solution - Alcon; CiproDex Ophthalmic; CiproDex Otic; CiproDex Sterile Otic Suspension; Ciprofloxacin/dexamethasone otic suspension; Dexamethasone/ciprofloxacinLatest Information Update: 15 Apr 2019
Price :
$50 *
At a glance
- Originator Bayer
- Developer Alcon; Bayer
- Class Anti-inflammatories; Fluorinated steroids; Fluoroquinolones; Glucocorticoids
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Otitis externa; Otitis media
- Discontinued Eye disorders
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon eye care devices business
- 08 Apr 2011 Novartis completes acquisition of Alcon
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals